Arsenate-induced apoptosis in murine embryonic maxillary mesenchymal cells via mitochondrial-mediated oxidative injury

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 1, 2010, Pages 25-34

  Singh, Saurabh ^a   Greene, Robert M ^a   Pisano, M Michele ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Apoptosis; Arsenate; Caspases; Mitochondria; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ARSENATE SODIUM; CASPASE 9; CASPASE INHIBITOR; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLEFT FACE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; EMBRYO CELL; EMBRYOTOXICITY; ENZYME ACTIVATION; EXENCEPHALY; FACE MALFORMATION; FEMALE; GASTROSCHISIS; HYPOPLASIA; MALE; MAXILLA; MESENCHYME CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL TOXICITY; MITOCHONDRION; MOUSE; MOUTH MALFORMATION; NEURAL TUBE DEFECT; NONHUMAN; OXIDATIVE STRESS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKULL MALFORMATION;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; ARSENATES; BCL-2-ASSOCIATED X PROTEIN; CASPASE 9; CELL SURVIVAL; CELLS, CULTURED; DRUG ANTAGONISM; EMBRYO, MAMMALIAN; ENZYME ACTIVATION; FEMALE; FREE RADICAL SCAVENGERS; MALE; MAXILLA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MESODERM; MICE; MICE, INBRED ICR; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

MURINAE;

EID: 75749092677     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20623     Document Type: Article

References (52)

1. Abernathy CO, Liu YP, Longfellow D, et al. 1999. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 107:593-597.
2. Agency for Toxic Substances and Disease Registry (ATSDR). 2007. Toxicological profile for arsenic. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
3. Applegate LA, Luscher P, Tyrrell RM. 1991. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res 51:974-978.
4. Aschengrau A, Zierler S, Cohen A. 1989. Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health 44:283-290.
5. Bhatacherjee V, Greene RM, Pisano MM. 2003. Divergence of EGF/TGFb signaling in embryonic orofacial tissue. In Vitro Cell Dev Biol 39: 257-261.
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Chen PH, Lan Chen-Che E, Chiou MH, et al. 2005. Effects of arsenic and UVB on normal human cultured keratinocytes: impact on apoptosis and implication on photocarcinogenesis. Chem Res Toxicol 18:139-144.
8. Chen YC, Lin-Shiau SY, Lin JK. 1998. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 177:324-333.
9. Danial NN, Korsmeyer SJ. 2004. Cell death: critical control points. Cell 116:205-219.
10. Debatin KM. 2004. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 53:153-159.
11. Dhulipala VC, Hanumegowda UM, Balasubramanian G, et al. 2004. Relevance of the palatal protein kinase A pathway to the pathogenesis of cleft palate by secalonic acid D in mice. Toxicol Appl Pharmacol 194:270-279.
12. Ferm VH, Carpenter SJ. 1968. Malformations induced by sodium arsenate. J Reprod Fertil 17:199-201.
13. Fulda S, Meyer E, Friesen C, et al. 2001. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 20:1063-1075.
14. Gebel TW. 1999. Arsenic and drinking water contamination. Science 283:1458-1459.
15. Golub MS, Macintosh MS, Baumrind N. 1998. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J Toxicol Environ Health B Crit Rev 1(3):199-241.
16. Greene RM, Linask KK, Pisano MM, et al. 1991. Transmembrane and intracellular signal transduction during palatal ontogeny. Genet Dev Biol 11:262-276.
17. Haga N, Fujita N, Tsuruo T. 2005. Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells. Cancer Sci 96:825-833.
18. Hei TK, Liu SX, Waldren C. 1998. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci USA 95:8103-8107.
19. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770-776.
20. Holson JF, Stump DG, Clevidence KJ, et al. 2000. Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats. Food Chem Toxicol 38:459-66.
21. HSDB. 2001. Hazardous Substances Data Base. National Library of Medicine. Available at: http://toxnet.nlm.nih.gov. accessed on March 5, 2009.
22. Jia L, Patwari Y, Srinivasula SM, et al. 2001. Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis. Oncogene 20:4817-4826.
23. Jou MJ, Jou SB, Chen HM, et al. 2002. Critical role of mitochondrial reactive oxygen species formation in visible laser irradiation-induced apoptosis in rat brain astrocytes (RBA-1). J Biomed Sci 9:507-516.
24. Kachinskas DJ, Phillipis MA, Qin Q, et al. 1994. Arsenate perturbation of human keratinocyte differentiation. Cell Growth Differ 5:1235-1241.
25. Kim R, Tanabe K, Uchida Y, et al. 2003. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma. Int J Mol Med 11:799-804.
26. Kitchin KT. 2001. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172:249-261.
27. Kowaltowski AJ, Castilho RF, Vercesi AE. 1996. Opening of the mitochondrial permeability transition pore by uncoupling or inorganic phosphate in the presence of Ca21 is dependent on mitochondrialgenerated reactive oxygen species. FEBS Lett 378:150-152.
28. Krajewski S, Tanaka S, Takayama S, et al. 1993. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714.
29. Lin Y, Kokontis J, Tang F, et al. 2006. Androgen and its receptor promote Bax-mediated apoptosis. Mol Cell Biol 26:1908-1916.
30. Lindgren A, Danielsson BR, Dencker L, et al. 1984. Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol Toxicol (Cph) 54:311-320.
31. Ling YH, Liebes L, Zou Y, et al. 2003. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 278:33714-33723.
32. Liu SX, Athar M, Lippai I, et al. 2001. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc Natl Acad Sci USA 98:1643-1648.
33. March of Dimes. 2008. Available at: www.marchofdimes.com. Accessed on March 5, 2009.
34. Martin SJ, Green DR. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell 82:349-352.
35. Mayer M, Noble M. 1994. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 91:7496-7500.
36. Nagymajtenyi L, Selypes A, Berencsi G. 1985. Chromosomal aberrations and fetotoxic effects of atmospheric arsenic exposure in mice. J Appl Toxicol 5:61-63.
37. Nugent P, Kusek JC, Pisano MM, et al. 2001. Convergence of cAMP, TGFbeta and retinoic acid signaling pathways in cells of the embryonic palate Life Sci 69(18):2091-2102.
38. Oya-Ohta Y, Daise T, Ochi T. 1996. Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat Res 357:123-129.
39. Pastides H, Calabrese EJ, Hosmer DW, et al. 1988. Spontaneous abortion and general illness symptoms among semiconductor manufacturers. J Occup Med 30:543-551.
40. Pisano MM, Mukhopadhyay P, Greene RM. 2003. Molecular fingerprinting of TGFbeta-treated embryonic maxillary mesenchymal cells. Orthod Craniofac Res 6:194-209.
41. Potchinsky MB, Lloyd MR, Weston WM, et al. 1998. Selective modulation of MAP kinase in embryonic palate cells. J Cell Physiol 76:266-280.
42. Rahman A, Vahter M, Ekström EC, et al. 2007. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am J Epidemiol 165:1389-1396.
43. Reers M, Smiley ST, Mottola-Hartshorn C, et al. 1995. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260:406-17.
44. Smith AH, Hopenhayn-Rich C, Bates MN et al. 1992. Cancer risks from arsenic in drinking water. Environ Health Perspect 7:259-267.
45. Spiegelstein O, Gould A, Wlodarczyk B, et al. 2005. Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies. Toxicol Appl Pharmacol 203:18-26.
46. Tabacova S, Hunter ES, 3rd, Gladen BC. 1996. Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence. Toxicol Appl Pharmacol 138:298-307.
47. U.S. EPA. 2001. EPA-815-Z-01-001. National Primary Drinking Water Regulations; Arsenic and Clarifications to Compliance and New Source Contaminants Monitoring. Final Rule Federal Register 66:6976.
48. Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181-182:211-217.
49. Wang A, Holladay SD, Wolf DC et al. 2006. Reproductive and developmental toxicity of arsenic in rodents: a review. Int J Toxicol 25:319-331.
50. Wang TS, Kuo CF, Jan KY, et al. 1996. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. Cell Physiol 169:256-268.
51. Warner DR, Greene RM, Pisano MM. 2005. Interaction between Smad 3 and Dishevelled in murine embryonic craniofacial mesenchymal cells. FEBS Lett 579:3539-3546.
52. Yamanaka K, Hasegawa A, Sawamura R, et al. 1991. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics in mice. Toxicol Appl Pharmacol 108:205-213.